Videos and Recordings - Technology
June 24, 2019
The ultra-sensitive measurement of proteins as biomarkers of Immuno-Oncology therapeutics using Simoa platforms. Biomarker World Congress and IO Pharma Congress, World Pharma Week, June 2019
NECN | January 25, 2019
An overview of Quanterix’ story, detailing our groundbreaking Simoa technology, the process of measuring biomarkers to detect and advance the treatment of disease, as well as the real world applications of how our technology is impacting how health care is practiced.
January 09, 2019
Quanterix CEO Kevin Hrusovsky presents at the 37th Annual J.P Morgan Healthcare Conference Access the Webcast and Q&A
December 12, 2018
Quanterix is proud to have sponsored the 2018 Powering Precision Health Summit in Amsterdam on December 12, where industry leaders joined for a day of discussion on the latest in medical research and exciting new opportunities to change the approach to healthcare. In this video, PPH Founder, Kevi
President, CEO & Chairman of Quanterix
We're passionate about the work we do and believe we can transform today’s sick care into tomorrow’s precision healthcare.
Interview with Kevin Hrusovsky, Chairman and CEO of Quanterix
Kevin Hrusovsky, Quanterix Chairman and CEO and Founder of Powering Precision Health, recently sat down with TetraScience CEO Alok Tayi to talk about the exciting work that Quanterix is doing in the area of clinical biomarkers and the business of diagnostics as well as a broader view
Early Diagnosis Through Predictive Biomarkers, NonInvasive Testing
In an excerpt from a panel discussion which took place at MedCity CONVERGE on July 11, 2018, Quanterix Chairman and CEO Kevin Hrusovsky joins other key innovators to discuss game-changing biotech advancements and the future of healthcare.
September 25, 2018
In a recent interview with Baystate Business, Quanterix Chairman and CEO and founder of Powering Precision Health, Kevin Hrusovsky explains the fundamentals of Quanterix technology and how it's disrupting the way healthcare is practiced.
Take a Virtual Tour
Quanterix' proprietary Simoa Bead Technology is based on the isolation of individual immunocomplexes on paramagnetic beads using standard ELISA reagents.